Multiple Endocrine Neoplasia Type 2A

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3226

A type of multiple endocrine neoplasia characterized by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands. (From Holland et al., Cancer Medicine, 3d ed, pp1172-75)

C3226

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977

CTRP

Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia.

Multiple Endocrine Neoplasia Type 2A

MEN 2A

MEA Type 2a

Multiple Endocrine Adenomatosis Type II

Multiple Endocrine Adenomatosis Type 2A

MEA Type II

Multiple Endocrine Neoplasia Type II

Multiple Endocrine Neoplasia, Type II

MEN Type II

Multiple Endocrine Adenomatosis, Type II

MEN Type 2a

Multiple Endocrine Neoplasia Type 2A

Multiple_Endocrine_Neoplasia_Type_II

Undetermined

Multiple Endocrine Neoplasia Type 2A

C3226

Multiple Endocrine Neoplasia Type 2A

Neoplastic Process

C0025268

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C123329